Literature DB >> 30763927

Duration of Observation for Detecting a Biphasic Reaction in Anaphylaxis: A Meta-Analysis.

Tae-Hyung Kim1, Soon Ho Yoon1, Hyunsook Hong2, Hye-Ryun Kang3,4, Sang-Heon Cho3,4, Suh-Young Lee5,6.   

Abstract

BACKGROUND: We conducted a meta-analysis to determine a practical observation time for detecting a biphasic reaction after resolution of the initial anaphylactic reaction.
METHODS: A systematic literature search identified studies on adult patients with anaphylaxis and a subsequent biphasic reaction due to various causes that contained sufficient data to extract outcomes. The outcomes were pooled using a random-effects model.
RESULTS: Twelve studies with a total of 2,890 adult patients with anaphylaxis and 143 patients with a biphasic reaction were included. In terms of the pooled negative predictive value, 1 h of observation achieved a 95.0% negative predictive value and ≥6 h of observation provided a 97.3% negative predictive value (95% CI: 95.0-98.5). The negative predictive value for a biphasic reaction increased with a longer observation time after initial anaphylaxis, and the increasing trend slowed down from 6 h of observation time. The pooled additional incidence rates of biphasic reactions per 100 person-hours after 1- and 4-h observations were 0.45 (95% CI: 0.20-1.04) and 0.41 (95% CI: 0.19-0.87), respectively. After > 8-12 h of postanaphylactic observation, the negative predictive value reached > 98%, while the additional incidence per 100 person-hours was < 0.10.
CONCLUSIONS: An observation time of ≥6 h after resolution of an initial anaphylaxis symptom can exclude recurrence of a secondary reaction in > 95% of patients. Although longer observation periods resulted in the detection of more biphasic reactions, 6-12 h of observation time would be practical, supporting current relevant guidelines.
© 2019 S. Karger AG, Basel.

Entities:  

Keywords:  Anaphylaxis; Biphasic reaction; Meta-analysis; Observation

Mesh:

Year:  2019        PMID: 30763927     DOI: 10.1159/000496092

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  6 in total

1.  Emergency treatment of anaphylaxis: concise clinical guidance.

Authors:  Andrew F Whyte; Jasmeet Soar; Amy Dodd; Anna Hughes; Nicholas Sargant; Paul J Turner
Journal:  Clin Med (Lond)       Date:  2022-07       Impact factor: 5.410

Review 2.  Evidence update for the treatment of anaphylaxis.

Authors:  Amy Dodd; Anna Hughes; Nicholas Sargant; Andrew F Whyte; Jasmeet Soar; Paul J Turner
Journal:  Resuscitation       Date:  2021-04-23       Impact factor: 5.262

3.  Safely Reducing Hospitalizations for Anaphylaxis in Children Through an Evidence-Based Guideline.

Authors:  Lukas K Gaffney; John Porter; Megan Gerling; Lynda C Schneider; Anne M Stack; Dhara Shah; Kenneth A Michelson
Journal:  Pediatrics       Date:  2022-02-01       Impact factor: 9.703

4.  Simulation of Health and Economic Benefits of Extended Observation of Resolved Anaphylaxis.

Authors:  Marcus Shaker; Dana Wallace; David B K Golden; John Oppenheimer; Matthew Greenhawt
Journal:  JAMA Netw Open       Date:  2019-10-02

5.  Should steroids be used for anaphylaxis after the COVID-19 vaccine?

Authors:  Youngho Seo; Taekyu Ahn; Jinhui Paik; Soo Kang
Journal:  Clin Exp Emerg Med       Date:  2021-12-31

6.  Incidence and timing of biphasic anaphylactic reactions: a retrospective cohort study.

Authors:  Motohiro Ichikawa; Akira Kuriyama; Seigo Urushidani; Tetsunori Ikegami
Journal:  Acute Med Surg       Date:  2021-07-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.